Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

<i>Intersex-like</i> ( <i>IXL</i> ) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 Amplification

1 Mar 2007

Abstract excerpt

Pancreatic cancer is a highly aggressive disease characterized by poor prognosis and vast genetic instability. Recent microarray-based, genome-wide surveys have identified multiple recurrent copy number aberrations in pancreatic cancer; however, the target genes are, for the most part, unknown. Here, we characterized the 19q13 amplicon in pancreatic cancer to identify putative new drug targets. Copy number...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Glioma Diagnosis and Treatment
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17332321
DOI: 10.1158/0008-5472.can-06-3387

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

<i>Intersex-like</i> ( <i>IXL</i> ) Is a Cell Survival Regulator in Pancreatic Cancer with 19q13 AmplificationPMID 17332321Read ↗

Characterization of the 7q21‐q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancerSemantic proximity Read ↗

Integrated genomic, transcriptomic, and RNA-interference analysis of genes in somatic copy number gains in pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

High-resolution characterization of the pancreatic adenocarcinoma genomeSemantic proximity Read ↗

Genome-Wide Array-Based Comparative Genomic Hybridization Reveals Multiple Amplification Targets and Novel Homozygous Deletions in Pancreatic Carcinoma Cell LinesSemantic proximity Read ↗

Identification of <i>SMURF1</i> as a possible target for 7q21.3‐22.1 amplification detected in a pancreatic cancer cell line by in‐house array‐based comparative genomic hybridizationSemantic proximity Read ↗

Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification.Semantic proximity Read ↗

Chromosome 9p21.3 Coordinates Cell Intrinsic and Extrinsic Tumor SuppressionSemantic proximity Read ↗

Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancerSemantic proximity Read ↗

High-Resolution Genomic and Expression Profiling Reveals 105 Putative Amplification Target Genes in Pancreatic CancerSemantic proximity Read ↗

Functional characterization of the 19q12 amplicon in grade III breast cancersSemantic proximity Read ↗

Epigenetic inactivation of IRX4 is responsible for acceleration of cell growth in human pancreatic cancerSemantic proximity Read ↗

Integrated analysis of copy number alterations and loss of heterozygosity in human pancreatic cancer using a high-resolution, single nucleotide polymorphism array.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.